198 related articles for article (PubMed ID: 28728292)
1. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization].
Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292
[No Abstract] [Full Text] [Related]
2. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
3. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
[TBL] [Abstract][Full Text] [Related]
4. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
5. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
6. A liquid biopsy-based method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients.
Zhang H; Gao P; Xiao X; Heger M; Geng L; Fan B; Yuan Y; Huang C; Chen G; Liu Y; Hu Y; Yu X; Wu S; Wang L; Wang Z
Int J Oncol; 2017 Apr; 50(4):1075-1086. PubMed ID: 28350107
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.
Li H; Meng QH; Noh H; Batth IS; Somaiah N; Torres KE; Xia X; Wang R; Li S
Cancer Lett; 2017 Sep; 403():216-223. PubMed ID: 28652021
[TBL] [Abstract][Full Text] [Related]
8. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.
Ning N; Zhan T; Zhang Y; Chen Q; Feng F; Yang Z; Liu Z; Xu D; Wang F; Guo Y; Xing J; Guan Y; Cui W
Clin Chim Acta; 2014 Jun; 433():69-75. PubMed ID: 24607330
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
[TBL] [Abstract][Full Text] [Related]
10. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.
Chen YY; Xu GB
Med Oncol; 2014 Dec; 31(12):240. PubMed ID: 25361883
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
Sun B; Liu H; Wang S; Xiang J; Liu X
J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
[TBL] [Abstract][Full Text] [Related]
14. The Isolation and Analysis of Circulating Tumor Cells.
Guo T; Stankiewicz E; Mao X; Lu YJ
Methods Mol Biol; 2019; 2054():115-128. PubMed ID: 31482451
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus: A STROBE-compliant study.
Ge L; Song Y; Yang F; Zhao G; Lu M; Zhang S; Ma L
Medicine (Baltimore); 2020 May; 99(22):e20615. PubMed ID: 32481476
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer.
Chen L; Zhou W; Ye Z; Zhong X; Zhou J; Chen S; Liu W; Sun Y; Ren L; Tan X; Cui J; Zeng Z; He W; Ke Z
ACS Appl Mater Interfaces; 2022 Aug; 14(31):35389-35399. PubMed ID: 35904812
[TBL] [Abstract][Full Text] [Related]
19. Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells.
Oulhen M; Pailler E; Faugeroux V; Farace F
Methods Mol Biol; 2017; 1634():133-141. PubMed ID: 28819846
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance.
Li Y; Zhang X; Liu D; Gong J; Wang DD; Li S; Peng Z; Li Y; Wang X; Lin PP; Li M; Shen L
Clin Cancer Res; 2018 Nov; 24(21):5261-5271. PubMed ID: 30012565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
